Cancer Australia PdCCRS recipients
2018/19 research funding
Total funding for these CA research grants in 2018/19 is $800,000. The five projects to benefit from this funding are:
Kate Vandyke – South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia
Project title: Increasing drug delivery and improving the quality of life for multiple myeloma patients.
Laura Bray – Queensland University of Technology, Institute of Health and Biomedical Innovation
Project title: Development of a translational bioengineered microenvironment model to advance pre-clinical acute myeloid leukaemia research
Michelle Henderson – Children’s Cancer Institute, Sydney, New South Wales
Project title: Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children
Jenny Wang – Children’s Cancer Institute, Sydney, New South Wales
Project title: Therapeutic targeting of a novel self-renewal signalling in leukaemia stem cells
Gabriela Brumatti – Walter and Eliza Hall Institute, Melbourne, Victoria
Project title: Targeting multidrug resistance protein 1 (MDR1) enhances the efficacy of Smac-mimetic-based therapy in acute myeloid leukaemia.
CA uses the National Health and Medical Research Council (NH&MRC) research grants management system.
Applications for grants go through two rounds of assessment:
Grants assessed and ranked according to the NH&MRC grants peer review process. Applications assessed by CA against outcomes and impact, translatability, collaborations, and consumer involvement.
The CA partnership also provides an opportunity for funds gifted to the Leukaemia Foundation for disease-specific research, be directed towards high quality research, and for grants to be co-funded with CA.Posted on December 16th, 2019
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.